Search

Author/Creator Boyer, N

1. A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy. (30th December 2014)

Authors:
Laouénan, C; Guedj, J; Peytavin, G; Nguyen, TH Tram; Lapalus, M; Khelifa‐Mouri, F; Boyer, N; Zoulim, F; Serfaty, L; Bronowicki, J‐P; Martinot‐Peignoux, M; Lada, O; Asselah, T; Dorival, C; Hézode, C; Carrat, F; Nicot, F; Marcellin, P; Mentré, F
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 4:Number 1(2015:Jan.)
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Issue 12 (10th August 2009)

Authors:
Moucari, R; Ripault, M-P; Martinot-Peignoux, M; Voitot, H; Cardoso, A-C; Stern, C; Boyer, N; Maylin, S; Nicolas-Chanoine, M-H; Vidaud, M; Valla, D; Bedossa, P; Marcellin, P
Journal:
Gut
Issue:
Volume 58:Issue 12(2009)
Page Start:
1662
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Issue 4 (25th September 2007)

Authors:
Asselah, T; Bieche, I; Narguet, S; Sabbagh, A; Laurendeau, I; Ripault, M-P; Boyer, N; Martinot-Peignoux, M; Valla, D; Vidaud, M; Marcellin, P
Journal:
Gut
Issue:
Volume 57:Issue 4(2008)
Page Start:
516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗